A Clinical Study to Map the HLA Genomic Region in the Greek Population

Recruiting Observational Study
Healthy Respiratory Disease Chronic Renal Failure Cardiovascular Diseases Metabolic Disease Psychiatric Disorder Neurologic Disorder Gastrointestinal Diseases Haematologic Disease Rheumatologic Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
12,000 (estimated)
Sponsor
Athens LifeTech Park · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The aim of GENESIS clinical study is to map the HLA genomic region in the Greek population and evaluate possible correlations with selected underlying diseases.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: The study will include adult subjects (age ≥ 18) that: * possess a Greek social security number and are visiting hospitals/clinics, and/or other private laboratory institutions (incl. clinics and health care groups) as part of standard clinical practice in Greece, * are willing…
Contacts

Efi Giannopoulou

+306974784009

egiannopoulou@lifetechpark.com

CONTACT